Data for increased Rho kinase activity in type 2 diabetic patients

The data presented in this article are related to the research article entitled “Enhanced Rho-Kinase Activity: Pathophysiological Relevance in Type 2 Diabetes” [1]. Rho-Kinase has attracted a great deal of interest as a novel therapeutic target in cardiovascular diseases. These data describe the obs...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Lei, Tan, Lun, Lai, Jinsheng, Li, Sheng, Wang, Dao Wen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2016
Materias:
Data Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5120266/
https://www.ncbi.nlm.nih.gov/pubmed/27896306
http://dx.doi.org/10.1016/j.dib.2016.11.032
_version_ 1782469205819392000
author Liu, Lei
Tan, Lun
Lai, Jinsheng
Li, Sheng
Wang, Dao Wen
author_facet Liu, Lei
Tan, Lun
Lai, Jinsheng
Li, Sheng
Wang, Dao Wen
author_sort Liu, Lei
collection PubMed
description The data presented in this article are related to the research article entitled “Enhanced Rho-Kinase Activity: Pathophysiological Relevance in Type 2 Diabetes” [1]. Rho-Kinase has attracted a great deal of interest as a novel therapeutic target in cardiovascular diseases. These data describe the observed relationship of Rho-Kinase activity with type 2 diabetic patients. Rho-Kinase activity is determined by immunoblotting of peripheral blood leukocytes with the Phospho-Thr853 in the myosin-binding subunit of myosin light-chain phosphatase. The level of IL-6 is measured using Enzyme-linked immunosorbent assay.
format Online
Article
Text
id pubmed-5120266
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-51202662016-11-28 Data for increased Rho kinase activity in type 2 diabetic patients Liu, Lei Tan, Lun Lai, Jinsheng Li, Sheng Wang, Dao Wen Data Brief Data Article The data presented in this article are related to the research article entitled “Enhanced Rho-Kinase Activity: Pathophysiological Relevance in Type 2 Diabetes” [1]. Rho-Kinase has attracted a great deal of interest as a novel therapeutic target in cardiovascular diseases. These data describe the observed relationship of Rho-Kinase activity with type 2 diabetic patients. Rho-Kinase activity is determined by immunoblotting of peripheral blood leukocytes with the Phospho-Thr853 in the myosin-binding subunit of myosin light-chain phosphatase. The level of IL-6 is measured using Enzyme-linked immunosorbent assay. Elsevier 2016-11-16 /pmc/articles/PMC5120266/ /pubmed/27896306 http://dx.doi.org/10.1016/j.dib.2016.11.032 Text en © 2016 The Authors http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Data Article
Liu, Lei
Tan, Lun
Lai, Jinsheng
Li, Sheng
Wang, Dao Wen
Data for increased Rho kinase activity in type 2 diabetic patients
title Data for increased Rho kinase activity in type 2 diabetic patients
title_full Data for increased Rho kinase activity in type 2 diabetic patients
title_fullStr Data for increased Rho kinase activity in type 2 diabetic patients
title_full_unstemmed Data for increased Rho kinase activity in type 2 diabetic patients
title_short Data for increased Rho kinase activity in type 2 diabetic patients
title_sort data for increased rho kinase activity in type 2 diabetic patients
topic Data Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5120266/
https://www.ncbi.nlm.nih.gov/pubmed/27896306
http://dx.doi.org/10.1016/j.dib.2016.11.032
work_keys_str_mv AT liulei dataforincreasedrhokinaseactivityintype2diabeticpatients
AT tanlun dataforincreasedrhokinaseactivityintype2diabeticpatients
AT laijinsheng dataforincreasedrhokinaseactivityintype2diabeticpatients
AT lisheng dataforincreasedrhokinaseactivityintype2diabeticpatients
AT wangdaowen dataforincreasedrhokinaseactivityintype2diabeticpatients

Ejemplares similares